Antigen-fed macrophages were able to induce specific sensitization of unprimed syngeneic lymphocytes in vitro. The sensitized lymphocytes caused specific injury to target cells that carried the relevant antigens. In the present study, we investigated the in vivo activity of lymphocytes sensitized by antigen-fed macrophages. Mouse spleen cells were sensitized by macrophages that had been exposed to the radiation leukemia virus (RadLV). The sensitized lymphocytes, which were enriched for T-cells, were injected to syngeneic normal recipients and 4 days later the mice were challenged with RadLV-induced lymphoma cells. By following tumor growth and survival of mice, we have found that the sensitized lymphocytes protected the recipient mice against lymphoma development if injected 4 days before the tumor cells. The protective activity of the sensitized lymphocytes was radioresistant, but they could not protect irradiated hosts. It is suggested that macrophagemediated in vitro sensitization of lymphocytes induces initiator cells that can protect the recipient host by recruitment of a defensive immune response.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Cohen, I. R., Livnat, S.: The cell-mediated immune response: Interaction of initiator and recruited T-lymphocytes. Transplant. Rev. 29, 24–58 (1976)
Decleve, A., Lieberman, M., Ihle, J. N., Kaplan, H. S.: Biological and Serological characterization of radiation leukemia virus (RadLV). Proc. Natl. Acad. Sci. 73, 4675–4679 (1976)
Ilfeld, D., Carnoud, C., Cohen, I. R., Trainin, N.: In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. Int. J. Cancer 12, 213–222 (1973)
Julius, M. H., Simpson, E., Herzenberg, L. A.: A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3, 645–649 (1973)
Kedar, E., Schwartzbach, M., Raanan, Z., Hefetz, S.: In vitro induction of cell-mediates immunity to murine leukemia cells. II. Cytotoxic activity in vitro and tumor-neutralizing capacity of antileukemia cytotoxic lymphocytes generated in macrocultures. J. Immunol. Methods 16, 39–58 (1977)
Lieberman, M., Kaplan, H. S.: Leukemogenic activity of filtrates from radiation-induced lymphoid tumors in mice. Science 130, 387–388 (1959)
Lieberman, M., Niwa, O., Decleve, A., Kaplan, H. S.: Continuous propagation of radiation leukemia virus on C57BL mouse embryo fibroblast line, with attenuation of leukemogenic activity. Proc. Natl. Acad. Sci. USA 70, 1250–1253 (1973)
Lieberman, M., Kaplan, H. S., Decleve, A.: Anomalous viral expression in radiogenic lymphomas of C57BL/Ka mice. In: Biology of radiation carcinogenesis. Yuhas, J., Tennant, R., Regan, J. (eds.), pp. 237–244. New York: Raven Press 1976
Rollinghoff, M., Wagner, H.: In vitro induction of tumor-specific immunity: requirements for T-lymphocytes and tumor growth inhibition in vivo. Eur. J. Immunol. 3, 471–476 (1973)
Schechter, B., Treves, A. J., Feldman, M.: Specific cytotoxicity in vitro in lymphocytes sensitized in cultures against tumor cells. J. Natl. Cancer Inst. 56, 975–979 (1976)
Schechter, B., Segal, S., Feldman, M.: Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: Affinity chromatography on insolubilized histamine. J. Immunol. 120, 1268–1273 (1977)
Thomas, D. W., Shevach, E. M.: Nature of the antigenic complex recognized by T-lymphocytes. I. Analysis with an in vitro primary response to soluble protein antigens. J. Exp. Med. 144, 1263–1273 (1976)
Treves, A. J., Cohen, I. R.: Recruitment of effector T-lymphocytes against a tumor allograft by T-lymphocytes sensitized in vitro. J. Natl. Cancer Inst. 51, 1919–1925 (1973)
Treves, A. J., Carnoud, C., Trainin, N., Feldman, M., Cohen, I. R.: Enhancing T-lymphocytes from tumor-bearing mice suppress host resistance to syngeneic tumor. Eur. J. Immunol. 4, 722–727 (1974)
Treves, A. J., Cohen, I. R., Feldman, M.: Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro. J. Natl. Cancer Inst. 54, 777–780 (1975)
Treves, A. J., Cohen, I. R., Feldman, M.: Suppressor factor secreted by T-lymphocytes from tumor-bearing mice. J. Natl. Cancer Inst. 57, 409–414 (1976)
Treves, A. J., Schechter, B., Cohen, I. R., Feldman, M.: Sensitization of T-lymphocytes in vitro by syngeneic macrophages fed with tumor antigens. J. Immunol. 116, 1059–1064 (1976)
Treves, A. J., Feldman, M., Kaplan, H. S.: Macrophage-mediated in vitro sensitization of T-lymphocytes. I. Detection of murine leukemia virus-associated antigens. J. Natl. Cancer Inst. 58, 1527–1529 (1977)
Treves, A. J., Honsik, C., Lieberman, M., Decleve, A., Feldman, M., Kaplan, H. S.: In vitro sensitization of lymphocytes against murine viral associated antigens by antigen-fed macrophages. In: The macrophages and cancer. Proceedings of EURES Meeting. pp. 108–117, 1977
Treves, A. J., Decleve, A., Lieberman, M., Feldman, M., Kaplan, H. S.: Macrophage-mediated in vitro sensitization of lymphocytes. II. The detection of neoantigens on transformed lymphocytes and passages of normal fibroblasts. J. Immunol. 120, 1947 (1978)
Yano, A., Schwartz, R. H., Paul, W. E.: Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex. J. Exp. Med. 146, 828–843 (1977)
About this article
Cite this article
Treves, A.J., Honsik, C., Feldman, M. et al. Macrophage-mediated in vitro sensitization of lymphocytes. Cancer Immunol Immunother 6, 179–184 (1979). https://doi.org/10.1007/BF00205544
- Spleen Cell
- Protective Activity
- Leukemia Virus